Company intelligence / Profile preview

Invaron Pharmaceuticals

Kelowna, British Columbia, Canadanewswire.ca ↗

Ownership: Private
Development stage: Phase 3

Overview

Invaron Pharmaceuticals specializes in acquiring and registering niche drugs and medical devices from outside Canada to address unmet needs within the Canadian healthcare system. Its most notable program is the introduction and clinical validation of INVOcell, a novel intravaginal culture device for assisted reproduction. The company has reported successful pregnancies using this technology in Canadian clinical trials.

Therapeutic areas: OtherWomen's Health
Modalities: Medical deviceSmall molecule
Industry: Biotech

Partnerships

Columbia Laboratories (licensed STRIANT testosterone buccal system rights for Canada)

Beyond the preview

Go deeper on Invaron Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invaron Pharmaceuticals.

Explore the full profile